This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Investigators seek to determine whether Pioglitazone can prevent or delay the development of type 2 diabetes in individuals who have Impaired Glucose Tolerance (IGT).
Showing the most recent 10 out of 185 publications